MSPH
University of North Carolina at Chapel Hill, Chapel Hill, NC
BA, Bachelor of Business Administration (Finance)
University of Notre Dame, Notre Dame, IN
Sandra Talbird, MSPH, is Executive Director of Health Economics at RTI-HS. Her experience at RTI-HS includes designing and programming decision analytic economic models, including cost-effectiveness, cost-utility, cost-benefit, and budget-impact models, using Microsoft Excel and Visual Basic for Applications. She has also developed mathematical models including compartmental dynamic transmission models for infectious diseases and linear programs in various software packages. She has experience generating real-world evidence for economic models through retrospective analyses of patient registry data, medical chart review studies, and clinical trial data. Ms. Talbird also has extensive experience in preparing economic submissions to health technology assessment agencies and National Immunization Technical Advisory Groups in many countries.
Ms. Talbird's primary research focus has been in infectious disease and vaccines,including treatment and prevention strategies for COVID-19, Ebola virus disease, HIV, acute and chronic hepatitis B, hepatitis C, seasonal influenza, invasive meningococcal disease, P. vivax and P. falciparum malaria, pertussis, pneumococcal disease, respiratory syncytial virus, tetanus, tuberculosis, and varicella zoster virus.
Ms. Talbird is an active member of the International Society of Pharmacoeconomics and Outcomes Research. Her research has been presented at various professional conferences and published in several peer-reviewed journals, including AIDS, HIV Medicine, Pediatrics, Pharmacoeconomics, American Journal of Preventative Medicine, Value in Health, and Vaccine.